Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2009-10-09

Clinical Trial Update: Ursodeoxycholic Acid in Chronic Heart Failure [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 study of ursodeoxycholic acid for chronic heart failure, but the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: National Heart and Lung Institute | Conditions: Heart Failure, Congestive | Phase 2 | Status: UNKNOWN